BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21823117)

  • 1. Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.
    Kreimer AR; Schiffman M; Herrero R; Hildesheim A; González P; Burk RD; Porras C; Sherman ME; Demuth F; Cheung L; Bratti C; Cecilia Rodríguez A
    Int J Cancer; 2012 Jul; 131(1):211-8. PubMed ID: 21823117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
    Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
    Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
    J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic human papillomavirus-infected immature metaplastic cells and cervical neoplasia.
    van der Marel J; van Baars R; Alonso I; del Pino M; van de Sandt M; Lindeman J; ter Harmsel B; Boon M; Smedts F; Ordi J; Torné A; Jenkins D; Quint W
    Am J Surg Pathol; 2014 Apr; 38(4):470-9. PubMed ID: 24503756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
    Kreimer AR; Guido RS; Solomon D; Schiffman M; Wacholder S; Jeronimo J; Wheeler CM; Castle PE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):908-14. PubMed ID: 16702369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
    Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative approach to preneoplastic cervical lesions in postmenopause.
    Vetrano G; Aleandri V; Ciolli P; Scardamaglia P; Pacchiarotti A; Verrico M; Carboni S; Corosu R
    Anticancer Res; 2008; 28(6B):3941-4. PubMed ID: 19192654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of human papillomavirus (HPV) 16 and HPV18 viral loads for the detection of high-grade cervical intraepithelial neoplasia (CIN2+) in a cohort of African women living with HIV.
    Segondy M; Ngou J; Kelly H; Omar T; Goumbri-Lompo O; Doutre S; Mayaud P; Didelot MN
    J Clin Virol; 2018; 99-100():79-83. PubMed ID: 29353074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples.
    Chatzistamatiou K; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Skenderi A; Stamatopoulos K; Agorastos T
    Gynecol Oncol; 2021 Sep; 162(3):560-568. PubMed ID: 34210517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
    J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is routine ECC necessary in patients with HPV16 and normal cytology?
    Ureyen I; Toptas T; Uysal A
    Diagn Cytopathol; 2018 Dec; 46(12):1031-1035. PubMed ID: 30353715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management.
    Wentzensen N; Walker J; Schiffman M; Yang HP; Zuna RE; Dunn ST; Allen RA; Zhang R; Sherman M; Gold MA; Wang SS
    Int J Cancer; 2013 Jan; 132(1):148-54. PubMed ID: 22488167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV16 and HPV18 genotyping triage in young women with borderline cytology or mild dyskaryosis: effect of age on genotype-specific risk of high-grade CIN.
    McKenna M; McMenamin M; McDowell A
    Cytopathology; 2016 Aug; 27(4):261-8. PubMed ID: 26873051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.